Physostigmine

butyrylcholinesterase ; Homo sapiens







93 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
51 8064320 Metabolic effects of scopolamine and physostigmine in human brain measured by positron emission tomography. 1994 May 1
52 7907455 Mechanism of action of cholinesterase inhibitors in Alzheimer's disease. 1993 1
53 8248533 Brain selective inhibition of acetylcholinesterase: a novel approach to therapy for Alzheimer's disease. 1993 1
54 1601960 Determination of heptylphysostigmine in plasma by high-performance liquid chromatography with electrochemical detection. 1992 Jan 17 1
55 1791534 Intranasal absorption of physostigmine and arecoline. 1991 Aug 1
56 1904998 A model for carbamate and organophosphate-induced emesis in humans. 1991 Spring 1
57 1967018 Adrenergic-cholinergic imbalances: the physostigmine-syndrome is not antagonized by the MAO-A inhibitor brofaromine. 1990 Nov 1
58 2497488 Central and peripheral muscarinic actions of physostigmine and oxotremorine on avoidance responding of squirrel monkeys. 1989 1
59 2570433 Scopolamine and benzodiazepine models of dementia: cross-reversals by Ro 15-1788 and physostigmine. 1989 1
60 2683549 Central anticholinergic syndrome (CAS) in anesthesia and intensive care. 1989 1
61 3069749 Cortisol responses to cholinergic drugs in Alzheimer's disease. 1988 Oct 3
62 3074841 Structure-activity relationship of reversible cholinesterase inhibitors: activation, channel blockade and stereospecificity of the nicotinic acetylcholine receptor-ion channel complex. 1988 1
63 3150807 Physostigmine enhances blood flow-metabolism ratio in neocortex. 1988 Dec 1
64 2821940 Pharmacologic evaluation and structure activity relationships of a series of hemicholinium-3 (HC-3) analogs. 1987 Jul 1
65 3435078 Anatomy of cholinesterase inhibition in Alzheimer's disease: effect of physostigmine and tetrahydroaminoacridine on plaques and tangles. 1987 Dec 2
66 3601008 A comparison of the effects of two inhibitors on brain cholinesterase. 1987 Jun 2
67 3524957 Clinical pharmacokinetics of cholinesterase inhibitors. 1986 May-Jun 1
68 3797688 Acute and chronic effects of oral physostigmine and lecithin in Alzheimer's disease. 1986 1
69 3809224 Perioral behaviors induced by cholinesterase inhibitors: a controversial animal model. 1986 Dec 1
70 2580948 Substance P in human plasma is degraded by dipeptidyl peptidase IV, not by cholinesterase. 1985 May 1
71 3980055 Central cardiovascular effects of physostigmine in humans. 1985 Jan-Feb 1
72 3999598 [Ocular myasthenia]. 1985 Mar 1
73 6143326 Cholinergic modulation of stimulant-induced behavior. 1984 Mar 1
74 6470148 Central cholinergic stimulation causes adrenal epinephrine release. 1984 Sep 1
75 6487203 A cholinomimetic model of motion sickness and space adaptation syndrome. 1984 Aug 2
76 6511307 A new simple method for determining the kinetic constants of inhibited acetylcholinesterase. 1984 Sep-Oct 1
77 6516793 Perivascular cholinesterase and morphological blood-brain barrier function. 1984 Dec 1
78 6747844 Presynaptic inhibitory effect of Met-enkephalin on [14C] acetylcholine release from the myenteric plexus and its interaction with muscarinic negative feedback inhibition. 1984 Aug 1
79 6347034 Oral physostigmine and lecithin improve memory in Alzheimer disease. 1983 May 1
80 6840979 Acute administration of individual optimal dose of physostigmine fails to improve mnesic performances in Alzheimers Presenile Dementia. 1983 1
81 6752738 A signal detectability analysis of the effect of physostigmine on memory in patients with Alzheimer's disease. 1982 Summer 1
82 7135153 Alteration of ethanol-induced sleep latency by physostigmine in animals. 1982 1
83 7217205 Electron microscope localization of acetylcholinesterase and butyrylcholinesterase in the superior cervical ganglion of the cat. II. Preganglionically denervated ganglion. 1981 Mar 1
84 7298772 Quantitative determination of the cholinesterase inhibitor physostigmine in brain tissue samples using reversed-phase high-performance liquid chromatography. 1981 Oct 9 1
85 7188667 Physostigmine-atropine solution fails to reverse diazepam sedation. 1980 Jan 1
86 445230 The effects of periarterial nerve activation on coronary vessel tone in an isolated and perfused slab of beef ventricle. 1979 Mar 1
87 30564 Physostigmine for cardiac and neurologic manifestations of phenothiazine poisoning. 1978 Dec 1
88 203742 [Diagnosis and treatment of ocular myasthenia (author's transl)]. 1977 Dec 1
89 4343315 Cholinergic and non-cholinergic transmission in the medial geniculate nucleus of the cat. 1972 Oct 1
90 5315359 Distribution of cholinesterases in insects. 1971 1
91 13525672 The effect of enzyme inhibitors on the resting potential and on the ion distribution of the sartorius muscle of the frog. 1958 May 20 1
92 19873399 THE MECHANISM OF ENZYME-INHIBITOR-SUBSTRATE REACTIONS : ILLUSTRATED BY THE CHOLINESTERASE-PHYSOSTIGMINE-ACETYLCHOLINE SYSTEM. 1944 Jul 20 5
93 19873367 ZONE BEHAVIOR OF ENZYMES : ILLUSTRATED BY THE EFFECT OF DISSOCIATION CONSTANT AND DILUTION ON THE SYSTEM CHOLINESTERASE-PHYSOSTIGMINE. 1943 Jul 20 1